CD146/HER2 CAR-T
/ Essen Biotech
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 15, 2025
BAH2573-103: Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced Sarcomas
(clinicaltrials.gov)
- P1/2 | N=60 | Recruiting | Sponsor: Essen Biotech
New P1/2 trial • Ewing Sarcoma • Kaposi Sarcoma • Lymphoma • Oncology • Osteosarcoma • Sarcoma • Soft Tissue Sarcoma • Solid Tumor • Synovial Sarcoma
1 to 1
Of
1
Go to page
1